ReviewPharmaceuticals (Basel, Switzerland)2025

Rho Kinase (ROCK) Inhibitors in the Treatment of Glaucoma and Glaucoma Surgery: A Systematic Review of Early to Late Phase Clinical Trials.

Jit Kai Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.